Cardiology

Episodes 65-80 of 191

What Are the Latest Updates on the Clinical and Economic Impact of AF?
What Are the Latest Updates on the Clinical and Economic Impact of AF?
MinuteCE®
What Are the Latest Updates on the Clinical and Economic Impact of AF?
1.00 program credit
- Sean Pokorney, MD
1.00 program credit
Case Study - New Guideline Recommendations into Clinical Practice for the Patient with AF
Case Study - New Guideline Recommendations into Clinical Practice for the Patient with AF
MinuteCE®
Case Study - New Guideline Recommendations into Clinical Practice for the Patient with AF
1.00 program credit
- Manesh R. Patel, MD
1.00 program credit
Improving CKD Patient Outcomes with SGLT2 Inhibitors
Improving CKD Patient Outcomes with SGLT2 Inhibitors
Clinician's Roundtable
Improving CKD Patient Outcomes with SGLT2 Inhibitors
- Gates B. Colbert, MD
Cardiovascular Disease in T2D: Researchers Identify Potential Therapeutic Target for Underlying Cause
Cardiovascular Disease in T2D: Researchers Identify Potential Therapeutic Target for Underlying Cause
Heart Matters
Cardiovascular Disease in T2D: Researchers Identify Potential Therapeutic Target for Underlying Cause
New Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
New Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
Heart Matters
New Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
AHA Identifies CKM Syndrome: A First Step in Managing Patients with CVD
AHA Identifies CKM Syndrome: A First Step in Managing Patients with CVD
Heart Matters
AHA Identifies CKM Syndrome: A First Step in Managing Patients with CVD
- Javed Butler
- Chiadi Ndumele, M.D., Ph.D., M.H.S.
CKM Syndrome Linked to Heart, Kidney, and Metabolic Diseases
CKM Syndrome Linked to Heart, Kidney, and Metabolic Diseases
Heart Matters
CKM Syndrome Linked to Heart, Kidney, and Metabolic Diseases
Pharmacist-Prescribing and Hypertension Management: An Economic Benefit
Pharmacist-Prescribing and Hypertension Management: An Economic Benefit
Heart Matters
Pharmacist-Prescribing and Hypertension Management: An Economic Benefit
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
- Dave L. Dixon, PharmD, FACC, FCCP, FNLA, BCPS, BCACP, CDE, CLS
First ESC Guidelines on Cardiomyopathies Management
First ESC Guidelines on Cardiomyopathies Management
Heart Matters
First ESC Guidelines on Cardiomyopathies Management
Update of ESC Guidelines on Heart Failure in a Nutshell
Update of ESC Guidelines on Heart Failure in a Nutshell
Heart Matters
Update of ESC Guidelines on Heart Failure in a Nutshell
Main Messages of New ESC Guidelines for CVD Management in Diabetes
Main Messages of New ESC Guidelines for CVD Management in Diabetes
Heart Matters
Main Messages of New ESC Guidelines for CVD Management in Diabetes
Combined ESC Guidelines for the Entire ACS Spectrum
Combined ESC Guidelines for the Entire ACS Spectrum
Heart Matters
Combined ESC Guidelines for the Entire ACS Spectrum
Transformation of Treatment Strategies for ATTR Amyloidosis
Transformation of Treatment Strategies for ATTR Amyloidosis
Heart Matters
Transformation of Treatment Strategies for ATTR Amyloidosis
First ESC Guidelines on Cardiomyopathies - Diagnosis
First ESC Guidelines on Cardiomyopathies - Diagnosis
Heart Matters
First ESC Guidelines on Cardiomyopathies - Diagnosis
Improving Symptoms, Function, and Weight Loss in HFpEF Patients with Obesity
Improving Symptoms, Function, and Weight Loss in HFpEF Patients with Obesity
Heart Matters
Improving Symptoms, Function, and Weight Loss in HFpEF Patients with Obesity
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
- Javed Butler
A Discussion on Statins to Lower CVD Risk for HIV Patients
A Discussion on Statins to Lower CVD Risk for HIV Patients
Heart Matters
A Discussion on Statins to Lower CVD Risk for HIV Patients
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
- Steve Grinspoon, MD

5/10

Episodes 65-80 of 191

Title

Share on ReachMD

Welcome to Global Cardiology Academy

Welcome to Global
Cardiology Academy